Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives |
| |
Authors: | Wolin Ronald L Santillán Alejandro Barclay Tristin Tang Liu Venkatesan Hariharan Wilson Sandy Lee Doo Hyun Lovenberg Timothy W |
| |
Affiliation: | Johnson & Johnson Pharmaceutical Research and Development, LLC, 3210 Merryfield Row, San Diego, CA 92121, USA. rwolin@prdus.jnj.com |
| |
Abstract: | Several beta- and gamma-amino acid derivatives were prepared as glycine transport inhibitors and their ability to block the uptake of [(14)C]-glycine in COS7 cells transfected with human glycine transporter-2 (hGlyT-2) were evaluated. A range of lipophilic side chains were tolerated in the beta-amino acid series (i.e., Ph, CH(2)Ph, CH(CH(3))(2), and CH(2)CH(CH(3))(2)). In the gamma-amino acid series, minimal differences in potency were observed between the alpha,beta-unsaturated analogs and the corresponding saturated derivatives. In both series, a 4-biphenyl or 4-phenoxyphenyl substituent appended to the urea or cyanogunaidine moiety was necessary for in vitro activity. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|